Bivalirudin Injection (Bivalirudin (Angiomax))- FDA

Bivalirudin Injection (Bivalirudin (Angiomax))- FDA can suggest

Suresh Kumar AO 9447117677 4 Com. Udaya kumar AGM (VRS) 9447121314 2. Roshan Kumar AO 9447555300 2 Bivalirudin Injection (Bivalirudin (Angiomax))- FDA. Praveen Kumar AO 9847273142 3 Com. Madhu Pavithran AO 9400390009 4 Com. Anil kumar JTO 9447577577 05. Manager (CSS Cadre) from the Vacancy Year 2015 onwards. In this regard, we requested the BSNL Management to depute Sr. BSNL Management assure to depute the Sr.

Advocate to argue in this case on 09. Yesterday after the arguments are over, the judgment is reserved. Some Senior candidates promoted earlier though Seniority-Cum-fitness quota aggrieved due to the wrong fixation of their seniority in the list no. Astro app net Chennai CAT directed the respondent (BSNL) to consider the representations of the applicants aggrieved due to disputed provisional seniority list no.

Yojana Das, Director(Finance), BSNL Board and discussed regarding:(a) Consideration of request transfers in the Cadre of Accounts Officers:-We requested Director (Finance), BSNL Board to consider the long pending request transfers in the Cadre of AOs. We informed Director (Finance), BSNL Board that Accounts Personnel are waiting for their request transfers since long and transfer cases are pending for approval of Director (Finance).

We appraised Director (Finance) that Accounts personnels are working in other Circles without their family in Covid-19 Pandemic situations and facing lot of problems. After patience hearing Director(Finance) assured to consider the request transfer cases. In this regard GS handed over the copy of the letter to Director(Finance) for taking necessary action. Director(Finance) assured to look into the matter.

Director(Finance) appreciated our concern and mentioned that BSNL Management seriously Bivalirudin Injection (Bivalirudin (Angiomax))- FDA with DoT regularly and we will expect some amount in near future.

GS handed over the Bivalirudin Injection (Bivalirudin (Angiomax))- FDA of the letter addressed to Secy(T), DoT to Director(Finance). Despite of repeated requests, the claim regarding monthly deducted subscription list has not been received from most of the Bivalirudin Injection (Bivalirudin (Angiomax))- FDA. It has been decided to conduct CWC Meeting at Thiruvananthapuram (Kerala) on 6th and 7th March 2021.

All the CHQ Office Bearers, Circle Secretaries, Circle Presidents and CWC Members are requested to book their onward and return tickets accordingly. Notification in this regard will be issued shortly after fixing the Meeting Venue and Accommodation. GS SNEA- In response to GS SNEA request regarding to join and support the Agitation Programme w. He further sought positive response from SNEA that United Forum has to be revived for mounting pressure on the Management for the Regular CPCs else better Career Progression by implementing the Khan Committee Recommendations in true spirit and real sense, for the betterment of the Executives of BSNL.

Goyal, PGM (Pers) CO BSNL and discussed regarding: (a) JTO to SDE (T) Promotion: We enquired about the status of JTO (T) to SDE promotion. DPC work is completed and Personnel Bivalirudin Injection (Bivalirudin (Angiomax))- FDA is trying its best to issue JTO (T) to SDE (T) promotion orders shortly. Since AIBSNLEA CHQ has received more than 400 representations which have already been forwarded to Pers.

Branch, we requested PGM (Pers) to consider the views of AIBSNLEA also before finalization of the Seniority list No. We informed PGM (Pers. PGM Bivalirudin Injection (Bivalirudin (Angiomax))- FDA mentioned that all request transfers are pending for the discussion with Director (Finance) and after clearance from the Bivalirudin Injection (Bivalirudin (Angiomax))- FDA (Fin), it will be issued immediately.

The case has been discussed with DGM (Pers-Legal) also. After patient hearing, PGM (Pers) mentioned that all necessary steps will be taken and DGM (Legal) will personally contact with the Sr. Advocate in CAT Chandigarh and all out efforts will be taken in the matter. However, he assured that we will discuss with our Sr. Advocate for making best efforts in this case. Sivakumar Participated virtually and addressed the 7th Bivalirudin Injection (Bivalirudin (Angiomax))- FDA Conference.

The Conference was conducted under the Presidentship of Com. Brij Mohan Dhyani Circle Secretary and CHQ Advisor welcomed one and all. Sivakumar, General Secretary at the outset thanked Com. Dhyani and other Circle Office bearers Bivalirudin Injection (Bivalirudin (Angiomax))- FDA inviting him for the 7th Circle Conference. He highlighted the fact that it is only AIBSNLEA which not only understands the actual issues of the Executives but also actively pursues the same with the Management for favourable results.

He explained the Status on the Bivalirudin Injection (Bivalirudin (Angiomax))- FDA pending HR issues as detailed below, which the Association is pursuing with the Management 1. EPF full Pension 6. He further mentioned that due to consistent efforts of AIBNLEA only, 13,000 Promotion orders were issued for various disciplines and assured that AIBSNLEA will always safe guard the interest of the Executives.

He further explained about the current financial condition and Cash Flow etc. Even after expiry of 15 months of assurance, 4 G is not allocated to BSNL.

Due to non-allocation of 4G, BSNL is put into continuous losses and in the financial year 2019-2020 BSNL in to a source of fibre of Rs. As per the approval of Bivalirudin Injection (Bivalirudin (Angiomax))- FDA Cabinet, EOI Tender notified by the BSNL inviting applications from the Domestic Vendors on 1.

He insisted the Govt. He insisted the DOT for the immediate release artery coronary disease Claims Payable to BSNL to the tune of Rs.

Immediate allotment of 4 G Spectrum to BSNL as already assured on 23. Immediate Regular Promotion in all the cadres of Executives and Non-Executives. He has made it clear that AIBSNLEA will keep up its separate identity and to continue to work to safeguard the Bivalirudin Injection (Bivalirudin (Angiomax))- FDA of all the Executives and requested the Executives to work hard to face the challenges and make BSNL viable and profitable and uphold Bivalirudin Injection (Bivalirudin (Angiomax))- FDA banner of BSNL and AIBSNLEA so high.

The following members were unanimously elected as Office Bearers for the 8th Circle Body for the next term Bivalirudin Injection (Bivalirudin (Angiomax))- FDA 3 years (2021-2024). Narendra Kumar, AO Circle Secretary: Com. Khajan Singh, AGM Finance Secretary: Com.

Further...

Comments:

There are no comments on this post...